Induction of Cancer Cell Death by Self-assembling Nanostructures Incorporating a Cytotoxic Peptide
Authors:
- Daniel J. ToftDTDaniel J. Toft
- Hao ChengHCHao Cheng
- Stephen SoukaseneSSStephen Soukasene
- Jing ChenJCJing Chen
- Srikumar M. RajaSRSrikumar M. Raja
- Vimla BandVBVimla Band
- Hamid BandHBHamid Band
- Vincent L. CrynsVCVincent L. Cryns
- Samuel I. StuppSSSamuel I. Stupp
- 14 April 2010
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 70 (8) , 3020-3026
Abstract
Nanotechnology offers novel delivery vehicles for cancer therapeutics. Potential advantages of nanoscale platforms include improved pharmacokinetics, encapsulation of cytotoxic agents, enhanced accumulation of therapeutics in the tumor microenvironment, and improved therapeutic structures and bioactivity. Here, we report the design of a novel amphiphilic molecule that self-assembles into nanostructures for intracellular delivery of cytotoxic peptides. Specifically, a cationic α-helical (KLAKLAK)2 peptide that is known to induce cancer cell death by membrane disruption was integrated into a peptide amphiphile (PA) that self-assembles into bioactive, cylindrical nanofibers. PAs are composed of a hydrophobic alkyl tail, a β-sheet forming peptide, and a bioactive peptide that is displayed on the surface of the nanofiber after self-assembly. PA nanostructures that included (KLAKLAK)2 were readily internalized by breast cancer cells, in contrast to the (KLAKLAK)2 peptide that on its own was not cell permeable. (KLAKLAK)2 nanostructures, but not the peptides alone, also induced breast cancer cell death by caspase-independent and Bax/Bak–independent mechanisms associated with membrane disruption. Significantly, (KLAKLAK)2 nanostructures induced cell death more robustly in transformed breast epithelial cells than in untransformed cells, suggesting a degree of tumor selectivity. Our results provide proof-of-principle that self-assembling PAs can be rationally designed to generate nanostructures that can efficiently deliver cytotoxic peptides to cancer cells. Cancer Res; 70(8); 3020–6. ©2010 AACR.Keywords
All Related Versions
This publication has 20 references indexed in Scilit:
- Self‐assembly of peptide amphiphiles: From molecules to nanostructures to biomaterialsPeptide Science, 2010
- A Bifunctional Targeted Peptide that Blocks HER-2 Tyrosine Kinase and Disables Mitochondrial Function in HER-2-Positive Carcinoma CellsCancer Research, 2005
- Activity of selective fully human agonistic antibodies to the TRAIL death receptors TRAIL‐R1 and TRAIL‐R2 in primary and cultured lymphoma cells: induction of apoptosis and enhancement of doxorubicin‐ and bortezomib‐induced cell deathBritish Journal of Haematology, 2005
- New Lytic Peptides Based on thed,l-Amphipathic Helix Motif Preferentially Kill Tumor Cells Compared to Normal CellsBiochemistry, 2003
- Self-Assembly Combining Two Bioactive Peptide-Amphiphile Molecules into Nanofibers by Electrostatic AttractionJournal of the American Chemical Society, 2003
- Peptide-amphiphile nanofibers: A versatile scaffold for the preparation of self-assembling materialsProceedings of the National Academy of Sciences, 2002
- Self-Assembly and Mineralization of Peptide-Amphiphile NanofibersScience, 2001
- Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and DeathScience, 2001
- Anti-cancer activity of targeted pro-apoptotic peptidesNature Medicine, 1999
- De Novo Antimicrobial Peptides with Low Mammalian Cell ToxicityJournal of Medicinal Chemistry, 1996